These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 8738859

  • 1. Effect of treatment with magnesium and potassium on mortality and reinfarction rate of patients with suspected acute myocardial infarction.
    Singh RB, Singh NK, Niaz MA, Sharma JP.
    Int J Clin Pharmacol Ther; 1996 May; 34(5):219-25. PubMed ID: 8738859
    [Abstract] [Full Text] [Related]

  • 2. Magnesium and potassium administration in acute myocardial infarction.
    Singh RB, Sircar AR, Rastogi SS, Garg V.
    Magnes Trace Elem; 1990 May; 9(4):198-204. PubMed ID: 2095163
    [Abstract] [Full Text] [Related]

  • 3. The effect of intravenous magnesium therapy on serum and urine levels of potassium, calcium, and sodium in patients with ischemic heart disease, with and without acute myocardial infarction.
    Rasmussen HS, Cintin C, Aurup P, Breum L, McNair P.
    Arch Intern Med; 1988 Aug; 148(8):1801-5. PubMed ID: 3041940
    [Abstract] [Full Text] [Related]

  • 4. [Identification of patients with acute myocardial infarction that may be discharged early: prospective evaluation with simple clinical and instrumental indicators].
    Murena E, Molero U, Moio N, Pisani A, Stingone MA, Guardascione A, Grassia V, Scilla C, Marino A, Sibilio G.
    Ital Heart J Suppl; 2001 Jul; 2(7):775-82. PubMed ID: 11508296
    [Abstract] [Full Text] [Related]

  • 5. Survival analysis within one year of first acute myocardial infarction: comparison between non-Q and Q wave myocardial infarction.
    Caires G, Pereira D, Freitas AD, Teixeira F, Leite R, Araújo JJ, Cardoso A, Pereira AC, Macedo ME, Diniz M.
    Rev Port Cardiol; 2000 Dec; 19(12):1223-38. PubMed ID: 11220119
    [Abstract] [Full Text] [Related]

  • 6. Effect of antioxidant-rich foods on plasma ascorbic acid, cardiac enzyme, and lipid peroxide levels in patients hospitalized with acute myocardial infarction.
    Singh RB, Niaz MA, Agarwal P, Begom R, Rastogi SS.
    J Am Diet Assoc; 1995 Jul; 95(7):775-80. PubMed ID: 7797808
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Early administration of nifedipine in suspected acute myocardial infarction. The Secondary Prevention Reinfarction Israel Nifedipine Trial 2 Study.
    Goldbourt U, Behar S, Reicher-Reiss H, Zion M, Mandelzweig L, Kaplinsky E.
    Arch Intern Med; 1993 Feb 08; 153(3):345-53. PubMed ID: 8285927
    [Abstract] [Full Text] [Related]

  • 10. Safety and efficacy of thrombolysis with alteplase (50 mg) plus tirofiban versus alteplase (100 mg) alone in acute myocardial infarction: preliminary findings.
    Sarullo FM, Pasquale PD, D'Alfonso G, Amerigo L, Cannizzaro S, Castello A.
    Ital Heart J; 2001 Aug 08; 2(8):605-11. PubMed ID: 11577835
    [Abstract] [Full Text] [Related]

  • 11. Clinical intervention studies on magnesium in myocardial infarction.
    Rasmussen HS.
    Magnesium; 1989 Aug 08; 8(5-6):316-25. PubMed ID: 2693849
    [Abstract] [Full Text] [Related]

  • 12. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].
    Sarullo FM, Schicchi R, Schirò M, Americo L, Bonnì G, Faraone N, Di Pasquale P, Castello A, Mauri F.
    Ital Heart J Suppl; 2000 Jan 08; 1(1):81-7. PubMed ID: 10832123
    [Abstract] [Full Text] [Related]

  • 13. [Risk factors as prognostic factors of hospital mortality in patients with acute myocardial infarction].
    Ivanusa M, Milicić D, Bozikov J, Ivanusa Z.
    Acta Med Croatica; 2007 Jun 08; 61(3):307-13. PubMed ID: 17629107
    [Abstract] [Full Text] [Related]

  • 14. Admission serum magnesium level does not predict the hospital outcome of patients with acute myocardial infarction.
    Madias JE, Sheth K, Choudry MA, Berger DO, Madias NE.
    Arch Intern Med; 2007 Jun 08; 156(15):1701-8. PubMed ID: 8694669
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction: FRAX.I.S. (FRAxiparine in Ischaemic Syndrome).
    Eur Heart J; 1999 Nov 08; 20(21):1553-62. PubMed ID: 10529323
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.